Virtu Financial LLC Oncternal Therapeutics, Inc. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$0.7 - $1.56 $30,465 - $67,894	43,522 New	43,522 $48,000
Q1 2022 May 17, 2022	SELL	$1.37 - $2.43 $54,479 - $96,631	-39,766 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$2.27 - $4.39 $36,226 - $70,060	15,959 Added 67.03%	39,766 $90,000
Q3 2021 Nov 12, 2021	BUY	$3.37 - $4.76 $80,229 - $113,321	23,807 New	23,807 $99,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.